Introduction {#sec1}
============

This is the 19th annual report of the European IVF-monitoring Consortium (EIM) under the umbrella of ESHRE containing the data on ART reported by 38 participating European countries in 2015 (Supplementary Data).

Eighteen previous reports, all published in *Human Reproduction* ([https://www.eshre.eu/Data-collection-and-research/Consortia/EIM/Publications.aspx](https://www.eshre.deu/Data-collection-and-research/Consortia/EIM/Publications.aspx)), covered treatment cycles from 1997 to 2014. As in previous reports, the printed version contains the five most relevant tables. Nineteen additional supplementary tables are available online. The settings of the data are consistent with those published in the previous reports, allowing optimal comparisons with earlier trends.

Materials and Methods {#sec2}
=====================

Aggregated data on various forms of ART were provided by 38 European countries, covering the following treatment modalities: IVF, ICSI, frozen embryo replacement (FER), egg donation (ED), IVM, pooled data on preimplantation genetic testing (PGT) and frozen oocyte replacement (FOR). In addition, data on IUI using either husband's/partner's semen (IUI-H) and donor semen (IUI-D) were included. The report includes treatments started between 1 January and 31 December in 2015. Data on pregnancies and deliveries are derived from follow-up of the treatments performed in 2015. Each register was informed about the need to obtain signed informed consent prior to the initiation of infertility treatment from each infertile individual for whom data have to be reported to the registry.

For the collection of the data, the national representatives of 43 countries were asked to fill out questionnaires and data were transmitted through an online software package, specially designed for the requirements of this data collection (Dynamic Solutions, Barcelona, Spain). The dataset of 2014 has been extended with an optional module on fertility preservation and now consists of 10 different modules. The software performs all calculations automatically and evaluates the plausibility of all results. If inconsistencies are detected, the administrator of the ESHRE central office (V.G.) contacts the national representative for clarification. The data were assembled similarly as in the previous reports making the results comparable. As usual, footnotes to the tables provide additional information on diverging results reported by individual countries, when applicable.

The terminology used was based on the glossary of The International Committee for Monitoring Assisted Reproductive Technology (ICMART) ([@ref13]).

Results {#sec3}
=======

Participation and data completeness {#sec4}
-----------------------------------

In [Table I](#TB1){ref-type="table"}, the number of institutions or clinics offering ART services and those performing IUI is listed together with all available treatment modalities. In comparison to the 2014 data ([@ref2]) not only has the number of reporting clinics increased (1279) in 2014 to 1343 in 2015, +4.9%), but also the overall number of reported treatments (776 556 in 2014 to 849 811 in 2015, +9.4%). Among the 51 European countries, eight are not members of the EIM Consortium ([Supplementary Table SI](#sup1){ref-type="supplementary-material"}), most being smaller countries not offering ART services. Georgia became a member of the EIM Consortium but has not yet provided any data to the Consortium. Croatia, Ireland, Slovakia and Turkey failed to deliver data. Of the 43 members, 38 submitted their data (88.4%) and in 18 countries (47.4%) all ART centres reported complete data sets. Currently, 1343 clinics reported their data (90.6% of all known clinics in Europe, 85.4% in 2013). As in 2014, the four European countries with the largest treatment numbers in 2015 were Spain (119 875 treatments), Russia (110723), Germany (96512) and France (93918).

###### 

Treatment frequencies after ART in European countries in 2015.

                        IVF clinics in the country   Cycles/million\*                                                                                                 
  --------------------- ---------------------------- ------------------ ------ ------ --------- --------- --------- -------- -------- ----- ------ --------- -------- ------
  Albania               8                            1                  8      1                112       50                 16                    178                
  Armenia               5                            4                  5      4      361       435       490                178            1      1465               
  Austria               28                           28                               1347      5220      2204               7                     8778      5331     1011
  Belarus               8                            6                  10     6      1489      1242      196       26       13             3      2969               
  Belgium               18                           18                 32     29     2909      14 239    11 699    580      802            71     30 300    14 272   2684
  Bosnia--Herzegovina                                2                  1      1      93        105       82                                       280                
  Bulgaria              35                           35                 1      1      933       6624      1643      37       612                   9849      7417     1372
  Cyprus                6                            6                  0             264       835       286       34       318                   1737      9650     2044
  Czech Republic        42                           41                 0                       13 228    10 357    1561     4961                  30 107             
  Denmark               21                           21                 56     54     6718      5737      4494      129      360            16     17 454    16 535   3068
  Estonia               5                            5                  5      5      623       1241      911                180                   2955      11 913   2247
  Finland               19                           19                 24     24     2567      2062      3839      44       831                   9343      9576     1704
  France                102                          102                186    186    20 477    40 864    30 101    1328     1072     76           93 918    8047     1457
  Germany               134                          130                0      0      17 382    55 904    23 226                                   96 512    6809     
  Greece                46                           46                 46     46     2872      13 922    4127      793      5182     5     248    27 149    13 000   2420
  Hungary               13                           11                 0      0      1098      4541      510       12       101                   6262               
  Iceland               1                            1                  1      1      198       181       252                108                   739       11 029   2238
  Italy                 201                          201                366    366    7985      47 344    12 903    2029     1615           1529   73 405    7199     1234
  Kazakhstan            23                           6                  23     6      1734      1883      667       132      600            4      5020               
  Latvia                5                            4                  5      4      372       769       452       103      441            6      2143               
  Lithuania             6                            2                  7      2      266       389                                                655                
  Macedonia             7                            4                  0      0      400       1519      157                58       2            2136               
  Malta                 2                            2                  2      0                231                                         80     311       3696     727
  Moldova               4                            3                  3      3      110       747       128                8                     993                
  Montenegro            5                            4                  6      4      9         439       58                                       506                
  Norway                11                           11                 11     11     3316      3140      3868                                     10 324    10 138   1985
  Poland                41                           33                        27     1050      14 382    9458      416      1031     30    124    26 491             
  Portugal              25                           25                 27     27     2376      3800      1573      104      797            10     8660      4327     831
  Romania               18                           12                 18     12     1196      1641      1021      3        68       1     5      3935               
  Russia                188                          144                0      0      34 497    41 137    25 397    2913     6270     127   382    110 723            
  Serbia                18                           3                  18     3      260       205       23                                       488                
  Slovenia              3                            3                  3      3      986       2355      1271      28       3              6      4649      12 255   2241
  Spain                 250                          231                365    280    5786      47 893    23 692    7045     34 176   20    1263   119 875            
  Sweden                17                           17                 0      0      5976      6155      5838      323      311                   18 603    10 203   1905
  Switzerland           28                           27                 0      0      947       4604      4487                                     10 038             
  The Netherlands       13                           13                 0      0      6509      7605      11 327    695                            26 136    8388     1543
  Ukraine               43                           38                 18     18     1666      9221      5868      1417     1037           55     19 264             
  UK                    84                           84                 105    105    21 188    23 725    15 443    1289     3321     4     491    65 461    5209     1001
  All                   1483                         1343               1352   1229   155 960   385 676   218 098   21 041   64 477   265   4294   849 811   7795     1432

FER: frozen embryo replacement, PGT: preimplantation genetic testing, ED: egg donation, FOR: frozen oocyte replacement.

Bosnia--Herzegovina consists of two parts: the Federation part and the Republic of Srpska.

Treatment cycles in IVF and ICSI refer to initiated cycles.

For Belgium, France, Iceland and Lithuania, treatment cycles refer to aspirations. For Austria, Belgium and France the total number of initiated cycles was only available for IVF and ICSI together, being 9101, 20 050 and 682 582, respectively.

For the Czech Republic and Bosnia and Herzegovina, no distinction between IVF and ICSI is made. All cycles are counted as ICSI. For Belgium, there are 881 aspiration cycles for which it is not known whether IVF or ICSI was performed, in 1367 aspirations IVF and ICSI was used.

Treatment cycles in FER refer to thawings.

For Czech Republic, Kazakhstan, Sweden and The Netherlands, treatment cycles refer to transfers.

Treatment cycles in PGD contain both fresh and frozen cycles and refer to initiated cycles in the fresh cycles (except for Finland where it refers to aspirations) and thawings in the frozen cycles (except for The Netherlands where it refers to transfers).

Treatment cycles in ED refer to transfer cycles and contain fresh and frozen cycles.

Treatment cycles in IVM refer to aspirations.

Treatment cycles in FOR refer to thawings.

Women of reproductive age and population were found at the following link: <https://population.un.org/wpp/DataQuery/>

Reporting methods and size of the clinics {#sec5}
-----------------------------------------

There is a large variability in the size of reporting institutions offering ART services, as defined by the number of treatment cycles ([Supplementary Table SII](#sup2){ref-type="supplementary-material"}). In 2015, clinics with cycle numbers between 200 and 499 were the most common (29.9%). When compared to previous EIM reports, the trend towards more large institutions may have stopped (≥1000 cycles, 17.9% in 2015 versus 18.3% in 2014 versus 17.8% in 2013 and 16.9% in 2012).

The motivation for collecting the data may be either voluntary or compulsory ([Supplementary Table SIII](#sup3){ref-type="supplementary-material"}). Among all participating countries, 19 fulfilled compulsory requirements (50.0%). In another 19 countries, the data collection was based on voluntary initiatives (50.0%). In countries with partial reporting, single personal initiatives continue to play a major role (five countries), as do medical organisations (in 11 countries). In 16 of 20 countries (80.0%) with incomplete data due to partial reporting, a voluntary data collection was present, whereas the data collection was more complete in countries with compulsory data collections (15 of 18 countries, 83.3%).

Aggregate data submission by single ART institutions to the respective national registries was still the most commonly used method (26 countries) in 2015. Individual cycles were reported from 12 countries ([Supplementary Table SIII](#sup3){ref-type="supplementary-material"}). Aggregate data collection was similarly prevalent in countries with complete and with partial reporting (61.1 versus 75.0%, respectively). Public access to individual clinic data was available only in 12 countries: Bosnia-Herzegovina, Republic of Srpska, Bulgaria, Estonia, Germany, Greece, Hungary, Romania, Slovenia, Spain, Sweden, The Netherlands and the UK. Additional financial support for the national registration was offered by the public, pharmaceutical industries or professional societies in 27 countries. In five countries, the centres covered part of the expenses while in three countries (Germany, Poland and Switzerland) all the expenses were covered by the centres alone. This information is missing in eight countries.

Number of treatment cycles per technique and availability {#sec6}
---------------------------------------------------------

In 2015, up to a total of 849 811 treatment cycles were reported to EIM (73 255 more than in 2014, +9.4%) ([Table I](#TB1){ref-type="table"}). Since the beginning of its activities, EIM has now recorded more than 8.8 million treatments with ART leading to the birth of more than 1.6 million infants ([Table II](#TB2){ref-type="table"}). In 2015, the most commonly used technique was ICSI (385 676 cycles, 45.4%) followed by FER (218 098, 25.7%) and IVF (155 960, 18.4%). Compared to 2014, all treatment modalities numbers increased, except IVM. The steepest increase in treatment number was observed in FER (+13.6%), in ED (+14.1%) and in PGT (+32.4%). A small number of countries reported fewer treatment cycles (Austria, Belarus and Bosnia-Herzegovina). As in 2014, two countries reported a large increment in treatment numbers (Russia and Spain), both with more participating ART institutions.

###### 

Number of institutions offering ART services, treatment cycles and infants born after ART in Europe, 1997--2015.

  Year    countries   clinics   Cycles      Cycle increase (%)   Infants born
  ------- ----------- --------- ----------- -------------------- --------------
  1997    18          482       203 225                          35 314
  1998    18          521       232 225     +14.3                21 433
  1999    21          537       249 624     +7.5                 26 212
  2000    22          569       275 187     +10.2                17 887
  2001    23          579       289 690     +5.3                 24 963
  2002    25          631       324 238     +11.9                24 283
  2003    28          725       365 103     +12.6                68 931
  2004    29          785       367 056     +0.5                 67 973
  2005    30          923       419 037     +14.2                72 184
  2006    32          998       458 759     +9.5                 87 705
  2007    33          1029      493 420     +7.7                 96 690
  2008    36          1051      532 260     +7.9                 107 383
  2009    34          1005      537 463     +1.0                 109 239
  2010    31          991       550 296     +2.4                 120 676
  2011    33          1314      609 973     +11.3                134 106
  2012    34          1354      640 144     +4.9                 143 844
  2013    38          1169      686 271     +7,2                 149 466
  2014    39          1279      776 556     +13,1                170 163
  2015    38          1343      849 811     +10.2                187 542
  total                         8 854 745                        1 665 994

Among the total of 541 636 fresh treatments (ICSI+IVF), 71.2% were performed with ICSI, showing a rise of +6.5% compared to 2014. The preponderance of ICSI over conventional IVF still continues to be more pronounced ([Fig. 1](#f1){ref-type="fig"}).

![Proportion of IVF versus ICSI in Europe, 1997--2015.](hoz038f1){#f1}

As in previous years, with 218 098 treatments, FER is rapidly gaining ground (+13.6%) but the relative proportion of FER to fresh treatments was stable (40.3% in 2015 and 37.8% in 2014). Switzerland is the country with the highest proportion of FER (44.7% of all treatment modalities) and Serbia with the lowest (4.7%).

Availability of ART in any particular country is calculated by dividing the number of treatment cycles by the number of women of reproductive age (15 to 45 years) ([Supplementary Table SIV](#sup4){ref-type="supplementary-material"}). Availability can only be calculated in the 18 countries with full coverage, and in those 18 countries, a huge variability in availability was observed, ART being most available in Denmark and least available in Malta. As a result, the proportion of newborns resulting from ART born in Denmark was 6.6% of all newborns in that country and 0.6% in Malta.

Pregnancies and deliveries after treatment {#sec7}
------------------------------------------

[Table III](#TB3){ref-type="table"} lists pregnancy (PR) and delivery rates (DR) after IVF or ICSI and after FER (after both IVF and ICSI). As in previous reports, data on the number of initiated cycles were incomplete. For that reason, we calculated outcome data per aspiration. Among the 38 participating countries, only 34 were able to provide pregnancy and delivery data after aspiration after IVF and ICSI (completeness rate: 89.5%). Six countries failed to provide those after FER (completeness rate: 84.2%). Complete coverage data on both pregnancies and deliveries were provided by 18 countries ([Supplementary Table SIV](#sup4){ref-type="supplementary-material"}). As in earlier reports, the PR and DR (all treatment modalities included) varied significantly from one country to another, with PR ranging from 19.6 to 44.0%, and DR ranging from 10.2 to 40.0% in fresh cycles after IVF or ICSI. After FER, the DR varied between 12.8 and 37.5% among different countries.

###### 

Results after ART in 2015.

                        IVF       ICSI      FER                                                                     
  --------------------- --------- --------- ------ ------ --------- ------ ------ --------- ------ ------ --------- -----
  Albania               112                               110       40.9   32.7   50        34.0   26.0   65        
  Armenia               796       361       40.4   33.8   435       37.7   29.2   490       38.0   31.8   597       1.4
  Austria               9101      1347      35.5   30.6   5220      30.4   25.9   2204      34.0   29.2   2414      2.9
  Belarus               2731      1435      39.2   30.8   1239      39.2   32.0   196       32.1   17.3   1116      0.9
  Belgium               20 050    2909      22.3   18.0   14 239    21.0   17.2   11 699    21.1   17.1   5702      4.7
  Bosnia--Herzegovina   105       93                                              82        44.8   24.1   200       0.2
  Bulgaria              7557      823       29.4   20.5   5770      26.5   19.1   1643      34.4   20.7   1830      2.8
  Cyprus                1099      243       30.0   28.0   799       41.8   39.0   286       24.1   18.9             
  Czech Republic        13 228                            12 872    25.6   16.3                           5590      5
  Denmark               12 455    6396      22.3   19.4   5718      24.8   21.9   4494      24.5   21.2   3865      6.6
  Estonia               1864      623       27.6   21.3   1241      27.3   19.0   911       19.4   12.8   633       4.5
  Finland               4629      2424      26.6   20.2   1982      26.4   20.8   3839      25.7   20.0   1667      3.0
  France                68 258    20 477    22.9   18.7   40 864    23.4   19.2   30 101    21.6   16.5   19 181    2.4
  Germany               73 286    15 990    26.4   19.4   51 448    26.9   19.7   23 226    25.3   17.1   20 878    2.8
  Greece                16 794    2684      27.5   20.5   13 407    26.5   16.3   4127      32.3   20.0   5059      
  Hungary               5638      1094      24.7          4539      22.9          510       37.8                    
  Iceland                         198       26.3   17.7   181       24.3   19.9   252       26.2   17.5   149       3.6
  Italy                 55 329    7107      23.0   15.8   43 107    19.6   12.5   12 903    26.2   18.6   11 275    2.3
  Kazakhstan            3617      1734      36.5   24.8   1883      42.8   32.2                           1618      0.4
  Latvia                1141      372       28.2   22.3   764       30.8   21.7   452       46.0   35.4   634       
  Lithuania                       266       33.8          389       33.4                                            
  Macedonia             1919      372       41.9   10.2   1378      40.2   34.3   157       29.3   14.6   655       2.8
  Malta                 231                               216                                             25        0.6
  Moldova               857       100       44.0   37.0   707       43.1   40.0   128       31.3   27.3             
  Montenegro            448       9         33.3   22.2   432       25.2   17.6   58        36.2   31.0   118       1.6
  Norway                6456      3316      26.5   22.4   3140      28.3   23.5   3868      19.3   15.4             
  Poland                15 432    1010      29.4   21.4   14 191    27.7   18.4   9458      31.2   19.8   5482      1.5
  Portugal              6176      2242      29.9   22.9   3613      26.1   19.3   1573      31.3   21.6   2260      2.6
  Romania               2837      1159      36.8   28.8   1598      33.6   27.8   1021      25.2   18.1   1236      0.7
  Russia                75 634    33 757    30.9   22.5   40 204    28.3   20.5   25 397    38.7   27.8   30 039    1.6
  Serbia                465       238       33.6   25.6   202       31.7   24.8   23        34.8   34.8   141       0.2
  Slovenia              3341      944       34.3   27.9   2274      26.6   20.4   1271      33.8   25.3   1172      5.7
  Spain                 53 679    5235      28.0   20.0   42 261    25.0   17.6   23 692    33.6   22.1   29 941    7.1
  Sweden                12 131    5594      30.7   25.7   5799      26.8   22.7                           4790      4.1
  Switzerland           5551      852       27.2   20.3   4232      23.3   17.9   4487      20.8   14.3   1836      2.1
  The Netherlands       14 114    5687      30.9   22.7   6820      32.0   23.9                                     
  Ukraine               10 887    1626      36.3   26.0   9028      31.1   24.4   5868      44.4   37.5   6795      1.7
  UK                    44 913    18 535    32.4   28.2   23 592    33.7   29.6   15 443    33.3   28.7   20 599    2.7
  All                   552 861   147 252   28.5   21.8   365 894   26.2   19.3   189 909   29.2   21.3   187 542   2.3

Total rates refer to these countries were all data were reported for the given technique.

^†^ART infants also include ED.

For IVF and ICSI, there were for France, Greece, Ireland, Kazakhstan, Russia and Spain, respectively, 177, 46, 1, 8, 543 and 27 deliveries with unknown outcome. These were accepted as singletons to calculate the ART infants.

For FER, there were for France, Greece, Kazakhstan, Russia and Spain, respectively, 41, 4, 2, 8 and 4 deliveries with unknown outcome. These were accepted as singletons to calculate the ART infants.

For the Netherlands, no data on the number of thawings were available.

For ED, there were for France, Greece, Kazakhstan, Poland, Russia, Spain and Ukraine respectively 1, 2, 1, 1, 23, 8 and 9 deliveries with unknown outcome. These were accepted as singletons to calculate the ART infants.

For PGD, there was for Russia one delivery with unknown outcome. This one was accepted as singleton to calculate the ART infants.

In the Czech Republic, IVF and ICSI were reported together, no details on pregnancies and deliveries.

Detailed accounts of cycle numbers, aspirations, transfers, pregnancies, deliveries in IVF, ICSI and FER (after both IVF and ICSI) are given in the [Supplementary Tables SV](#sup5){ref-type="supplementary-material"}, [SVI](#sup6){ref-type="supplementary-material"} and [SVII](#sup7){ref-type="supplementary-material"}. For the second time, information about 'freeze all' cycles was collected ([Supplementary Table SV](#sup5){ref-type="supplementary-material"}). As in 2014, 'freeze all' was carried out at the oocyte level in six reporting countries (15.8%) and at the embryonic level in 21 reporting countries (55.2%) (46.1%, in 2014: 18 countries).

Whereas in 2014 only 22 countries were able to provide egg/oocyte donation (ED) data, in 2015 the data from 29 of 38 participating countries are available (76.3%) (Supplementary Table SVIII). In most of the other countries, this technology is not being performed for legal reasons. Most donation cycles were carried out in Spain, Russia, the Czech Republic and Greece. Approximately 31 511 ED cycles were carried out with freshly collected oocytes, fewer with frozen oocytes (FOR, 13107 cycles). Pregnancy rates were only available per embryo transfer (ET), but were considerably higher with freshly donated oocytes (49.6%) than after thawing of oocytes (40.3%). The differences among countries were considerable, ranging between 16.7 and 58.1% after thawing. A total of 19 849 deliveries were counted, which considerably exceeds the 17 259 deliveries counted in 2014 (+15.0%). This increment is due to overall higher numbers of reported treatments with ED, regardless of whether eggs were frozen or not.

Age distribution {#sec8}
----------------

As in previous reports, the age distribution of women treated with IVF and ICSI varied among different countries ([Supplementary Tables SIX](#sup9){ref-type="supplementary-material"} and [SX](#sup10){ref-type="supplementary-material"}). Not all countries were able to provide data on the age distribution in ICSI and in IVF, some because no IVF treatments were carried out. As in 2013 and in 2014, the highest percentage of women aged 40 years and older undergoing aspiration for IVF was found in Greece, whereas the highest percentage of women aged \<34 years was found in Montenegro. Also in ICSI, the highest percentage of women aged 40 years and older undergoing aspiration was found in Greece, whereas the highest percentage of women undergoing aspiration aged \<34 years was recorded in Albania (as in 2013 and in 2014). Overall, the well-known age-dependent decline of the reported PR and DR was very similar in IVF and ICSI, but the differences among countries were considerable.

Although the age-related decline was present in FER cycles as well ([Supplementary Table SXI](#sup11){ref-type="supplementary-material"}), the outcome data of FER were generally higher than in the fresh cycles. In contrast, in ED donation cycles ([Supplementary Table SXII](#sup12){ref-type="supplementary-material"}) age of the recipient women did not impact on PR or on DR.

Number of embryos transferred and multiple births {#sec9}
-------------------------------------------------

The number of embryos transferred after IVF and ICSI together is presented in [Table IV](#TB4){ref-type="table"}. Although the specific number of elective single embryo transfers (SET) cannot be identified, the number of transfers of only one embryo per cycle continued to rise (37.7% in 2015, as compared to 34.9% in 2014), whereas the number of transfers of three or more embryos per cycle decreased ([Fig. 2](#f2){ref-type="fig"}). As in 2014, the same eight countries performed more than 50% SET (Austria, Belgium, Czech Republic, Denmark, Finland, Iceland, Poland and Sweden). Only one country with more than 40% of transfers with three embryos remained in 2015, i.e. Serbia. In Greece, 4.9% of all embryo transfers were carried out with four or more embryos.

###### 

Number of embryos transferred after ART and deliveries in 2015.

                                            IVF + ICSI          FER                                                       
  ----------------------------------------- ------------ ------ ------ ------ ----- -------- ------ ----- -------- ------ -----
  Albania                                   103          5.8    79.6   13.6   1.0   36       19.4   2.8   13       7.7    0.0
  Armenia                                   651          14.9   62.7   22.4   0.0   249      32.0   4.5   156      21.2   0.0
  Austria                                   5692         62.0   37.5   0.5    0.0   1766                  643             
  Belarus                                   2498         13.4   64.3   22.3   0.0   838      25.5   0.6   34       17.6   2.9
  Belgium                                   14 101       59.9   34.3   5.2    0.6   2976     8.8    0.2   2006     6.2    0.2
  Bosnia--Herzegovina                       476          13.7   45.8   39.5   1.0   128      30.5   1.6   20       25.0   0.0
  Bulgaria                                  4737         21.7   56.3   21.9   0.2   1269                  340             
  Cyprus                                                                                                                  
  Czech Republic                            10 344       66.3   32.6   1.2    0.0   2092     9.8    0.2   1727     9.8    0.3
  Denmark                                   9760         64.0   34.2   1.9    0.0   2498     8.3    0.1   953      8.2    0.0
  Estonia                                   1618         39.3   53.6   7.0    0.0   369      14.4   0.0   117      18.8   0.9
  Finland                                   3568         82.0   18.0   0.0    0.0   900                   767             
  France                                    46 946       42.4   52.1   5.2    0.4   11 678   13.8   0.1   4958     8.4    0.1
  Germany                                   56 112       21.6   69.2   9.2    0.0   13 239   21.5   0.6   3976     15.3   0.6
  Greece                                    11 428       20.6   55.1   19.3   4.9   2743     24.5   0.6   825      18.0   0.8
  Hungary                                   5129         20.8   57.3   18.2   3.8                                         
  Iceland                                   314          69.7   30.3                71       7.0    0.0   44       9.1    0.0
  Italy                                     37 975       28.8   48.3   21.0   1.9   6498     17.3   0.8   2403     8.7    0.2
  Kazakhstan                                                                        1036     17.3   1.4   168      9.5    0.0
  Latvia                                    880          33.1   65.7   1.2    0.0   249      16.8   0.8   160      5.8    1.0
  Lithuania                                                                                                               
  Macedonia                                 1637         25.8   67.1   7.1    0.0   510      16.5   0.8   23       30.4   0.0
  Malta                                     287                                     22       13.6   0.0                   
  Moldova                                                                                                                 
  Montenegro                                394          25.4   36.8   36.8   1.0   78       21.8   0.0   18       27.8   0.0
  Norway                                                                                                                  
  Poland                                    11 214       63.0   36.6   0.4    0.0   2821     10.6   0.3   1874     8.2    0.2
  Portugal                                  4479         29.9   68.5   1.7    0.0   1212     19.9   0.3   339      17.7   0.3
  Romania                                   2279         16.9   60.0   21.1   2.1   778      25.3   0.7   185      23.9   0.0
  Russia                                    59 934       32.9   61.5   5.5    0.2   15 833   19.1   0.6   7069     14.9   0.3
  Serbia                                    386          20.7   31.6   47.7   0.0   111      23.4   0.0                   
  Slovenia                                  2688         44.0   55.5   0.5    0.0   727      10.7   0.0   321      13.1   0.0
  Spain                                     33 039       27.9   67.4   4.7    0.0   8497     19.2   0.2   5237     15.0   0.2
  Sweden                                    9326         81.2   18.8   0.0    0.0   2750     4.4    0.0   1709     2.8    0.1
  Switzerland                               4043         32.1   58.1   9.7    0.0   929      17.8   0.2   642      15.0   0.0
  The Netherlands                                                                                                         
  Ukraine                                   7845         22.8   64.2   12.9   0.2   2630     19.0   0.5   2198     18.4   0.0
  UK                                        37 846       49.9   46.4   3.7    0.0   12 213   12.7   0.2   4434     13.4   0.4
  All[^\*^](#tblfn2){ref-type="table-fn"}   387 729      37.7   53.9   7.9    0.5   97 746   16.5   0.4   43 359   12.3   0.3

^\*^Totals refer only to these countries where data on number of transferred embryos and on multiplicity were reported.

![Number of embryos transferred in IVF and ICSI during fresh cycles in Europe, 1997--2015.](hoz038f2){#f2}

Additional details about the pregnancy and delivery data are given in Supplementary Tables SXIII and SXIV. The recorded incidence of pregnancy loss was 16.4% after IVF + ICSI (in 2014: 15.5%) and 20.6% after FER (in 2014: 18.6%). The recorded loss to follow-up was 6.3% after IVF + ICSI (in 2014: 9.9%) and 7.4% after FER (in 2014: 7.3%).

Since the first recorded European data sets, as recorded by EIM, the proportion of both twin and triplet deliveries was found to be declining. Twin and triplet deliveries were similar after IVF + ICSI treatments as after FER. Those countries with the highest proportion of SET also had the lowest twin and triplet delivery rates (the lowest in Sweden, 4.4 and 0%, respectively) after fresh cycles. The countries still proceeding with the transfer of three or more embryos in fresh cycles present with DR of twins ranging between 21.8% (Montenegro) and 32.0% (Bosnia-Herzegovina), and with DR of triplets ranging between 0.6% (Greece) and 4.5% (Armenia). Unfortunately, Finland with the highest SET rate of 82% did not report on multiplicity.

Regarding ED, of 15 178 deliveries with information regarding multiplicity, 3001 were twins (19.8%) and 37 were triplets (0.2%) (data not presented in tables).

Perinatal risks and complications {#sec10}
---------------------------------

In 2015, data on premature deliveries were available from 18 European countries (in 2014 from 20 countries). The incidence of premature delivery is listed according to the number of newborns in [Supplementary Table SXV](#sup15){ref-type="supplementary-material"}. The prematurity data resulting from fresh IVF and ICSI, from FER and from ED, are listed together. The incidence of extreme preterm birth (gestational weeks 20--27) reached 1.3% in singleton pregnancies (0.9% in 2014), 3.7% in twin pregnancies (3.4% in 2014) and 13.4% in triplet pregnancies (10.0% in 2014). A high incidence of very premature birth rates (gestational weeks 28--32) was found in twin pregnancies: 9.9% (in 2014: 10.7%) and in triplet pregnancies: 39.2% (in 2014: 34.9%). Term delivery (≥37 weeks) was 86.4% in singleton pregnancies, 44.7% in twin pregnancies and 7.5% in triplet pregnancies, all similar to the results achieved in 2014. Interestingly, the premature DR (\<37 weeks) of singleton pregnancies calculated per ET is similar to the premature DR of twin pregnancies ([Fig. 3](#f3){ref-type="fig"}).

![Proportion of premature deliveries (\<37 weeks of gestation in relation to pregnancies ≥37 weeks of gestation) in singleton, twin and triplet pregnancies in Europe, 2006--2015.](hoz038f3){#f3}

As in 2014, complications of various steps of ART, such as ovarian hyperstimulation syndrome (OHSS), haemorrhage, infections and maternal deaths, were reported by 31 countries ([Supplementary Table SXVI](#sup16){ref-type="supplementary-material"}). With 2167 cases, OHSS was the most common reported complication of ART (incidence rate: 0.44% of all reported cycles, compared to 0.3% in 2014 with 2040 cases). Other complications were much rarer, such as haemorrhage (0.11% of all treatment cycles), infections (0.01%) and maternal death (two per 850 000 treatment cycles). The circumstances of the observed maternal deaths were not provided.

Foetal reductions were reported from 26 countries and were performed in 0.06% of all treatment cycles. Most foetal reductions were reported by the UK, Spain and Russia, as in 2014.

PGT-M/SR/PGT-A {#sec11}
--------------

PGT-M/SR (for monogenic disorders or structural rearrangements) and PGT-A (for aneuploidy) activities were reported from 23 countries (22 in 2014, 20 in 2013). The number of treatment cycles was 21 041 (2.48% of all ART treatments, [Table I](#TB1){ref-type="table"}), which compared to 2014 represents a drastic rise in treatment numbers. These involved 16 685 fresh cycles and 4356 thawings, resulting in 6696 fresh ET and 4059 FER. In total, 2662 pregnancies (39.7% per transfer) and 2161 deliveries (32.3% per transfer) resulted from fresh cycles. Corresponding figures for FER were 1666 (41.0% per transfer) and 1398 (34.4% per transfer). The main contributor was Spain with 7045 cycles followed by Russia with 2913 cycles. A more detailed survey of PGT activities can be found in the annual reports of the ESHRE PGT Consortium ([@ref4]).

IVM {#sec12}
---

A total of 265 treatments with IVM were reported from eight countries (292 in 2014) ([Table I](#TB1){ref-type="table"}). Most IVM cycles were performed in Russia. A total of 154 transfers resulted in 45 pregnancies and 33 deliveries.

FOR {#sec13}
---

FOR was reported by 17 countries (16 in 2014), and this accounted for 4294 thawing cycles (3404 in 2014) ([Table I](#TB1){ref-type="table"}), 3478 transfers, 1067 pregnancies and 716 deliveries, Italy and Spain being the largest contributors (1529 and 1263 cycles, respectively).

IUI {#sec14}
---

Data on IUI-H (Supplementary Table SXVII) and IUI-D (Supplementary Table SXVIII) were collected by 1229 institutions in 26 and 22 countries, respectively ([Table V](#TB5){ref-type="table"}). Spain, Belgium and Denmark were the most active countries in both treatment modalities. Altogether, 189 764 treatments with IUI-H resulted in 14 886 deliveries (7.8%), whereas 49 514 treatments with IUI-D resulted in 5926 deliveries (12.0%). Many more treatment IUI cycles were reported in 2015 than in 2014, but the outcome results are similar to those reported earlier. In all three age groups (≤34, 35--39 and ≥40 years), most pregnancies led to singleton deliveries (90.6% in IUI-H, 92.1% in IUI-D). The twin and triplet DRs for IUI-H and IUI-D were generally low, depending on the age of the treated patient and were similar to those reported in previous years (twin deliveries: 8.9 and 7.3%, respectively; triplet deliveries: 0.5 and 0.6%, respectively).

###### 

IUI with husband or donor semen in 2015.

                                            IUI-H     IUI-D                                                                      
  ----------------------------------------- --------- -------- ------ ------- ------ ----- -------- ------ ------ ------- ------ -----
  Albania                                                                                                                        
  Armenia                                   571       98       17.2   90.8    9.2    0.0   313      60     19.2   91.7    8.3    0.0
  Austria                                                                                                                        
  Belarus                                   952       107      11.2   99.1    0.9    0.0                                         
  Belgium                                   13 162    769      5.8    95.3    4.4    0.3   8112     597    7.4    94.5    5.4    0.2
  Bosnia--Herzegovina                       191       17       8.9    94.2    5.8    0.0                                         
  Bulgaria                                  2976      171      5.7                         590      35     5.9                   
  Cyprus                                                                                                                         
  Czech Republic                                                                                                                 
  Denmark                                   10 339    1291     12.5   88.9    9.6    1.5   9924     879    8.9    95.2    4.4    0.3
  Estonia                                   139       6        4.3    100.0   0.0    0.0   91       4      4.4    100.0   0.0    0.0
  Finland                                   3126      284      9.1                         1171     138    11.8                  
  France                                    50 714    5065     10.0   89.7    9.9    0.3   3294     570    17.3   89.6    10.2   0.2
  Germany                                                                                                                        
  Greece                                    4561      313      6.9    94.2    5.8    0.0   287      41     14.3   95.1    4.9    0.0
  Hungary                                                                                                                        
  Iceland                                                                                                                        
  Italy                                     22 549    1588     7.0    90.9    8.2    0.9   513      61     11.9   88.5    9.8    1.6
  Kazakhstan                                810       25       3.1    100.0   0.0    0.0   125      8      6.4    100.0   0.0    0.0
  Latvia                                    96        10       10.4   85.7    14.3   0.0   53       6      11.3   100.0   0.0    0.0
  Lithuania                                                                                                                      
  Macedonia                                 1186      62       5.2    100.0   0.0    0.0   29       3      10.3   100.0   0.0    0.0
  Malta                                                                                                                          
  Moldova                                   102       7        6.9    100.0   0.0    0.0                                         
  Montenegro                                222       24       10.8   87.5    12.5   0.0                                         
  Norway                                    20 708    47       0.2    83.0    17.0   0.0   614      119    19.4   95.8    4.2    0.0
  Poland                                    9036      570      6.3    94.3    5.5    0.2   1729     173    10.0   96.3    3.7    0.0
  Portugal                                  2188      195      8.9    90.3    8.7    1.0   236      50     21.2   88.0    12.0   0.0
  Romania                                   2091      169      8.1    91.7    8.3    0.0   191      21     11.0   90.5    9.5    0.0
  Russia                                    10 013    1181     11.8   93.2    6.7    0.2   4128     574    13.9   90.9    6.3    2.8
  Serbia                                    408       28       6.9    89.3    10.7   0.0                                         
  Slovenia                                  246       18       7.3    88.9    11.1   0.0   1        0      0.0                   
  Spain                                     26 959    2713     10.1   88.9    10.7   0.4   11 944   1747   14.6   88.8    10.8   0.4
  Sweden                                                                                   760      115    15.1   100.0   0.0    0.0
  Switzerland                                                                                                                    
  The Netherlands                                                                                                                
  Ukraine                                   1570      128      8.2    89.6    10.4   0.0   468      53     11.3   92.5    7.5    0.0
  UK                                        4849                                           4941     672    13.6   94.9    4.6    0.4
  All[^\*^](#tblfn3){ref-type="table-fn"}   189 764   14 886   7.8    90.6    8.9    0.5   49 514   5926   12.0   92.1    7.3    0.6

^\*^Total refers to these countries where data were reported, and mean percentage was computed on countries with complete information.

Iceland 125 IUI with husband semen (IUI-H) and 177 IUI with donor semen (IUI-D) cycles performed without further information.

Italy: underestimation of deliveries because of high number of pregnancies is lost to follow-up.

Slovenia: Data from two clinics only.

Sum of fresh and FER ('cumulative') DR {#sec15}
--------------------------------------

[Supplementary Table SXIX](#sup19){ref-type="supplementary-material"} provides us with an estimate (not a true rate, as the data set presented here is cross-sectional) of a cumulative DR, calculated from the fresh ET and those carried out after thawing. The data are presented based on the sum of the fresh and FER deliveries and the number of aspirations of the same year as the denominator. As no data on deliveries were available from Hungary, Bosnia and Herzegovina and Lithuania, we were able to calculate cumulative delivery rates for 35 countries (38 countries in 2014). Whereas in all data taken together, the DR after the fresh cycle amounted to 20.0%, the cumulative DR was 28.9%. The countries with the highest benefit resulting from FER were Ukraine (+20.6%), Armenia (+19.6%) and Finland (+17.4). The countries with the lowest benefit resulting from FER were Belarus (+1.3%) and Macedonia (+1.4%).

Cross-border reproductive care {#sec16}
------------------------------

Eleven countries reported data on cross-border patients: Albania, Belarus, Denmark, Iceland, Macedonia, Malta, Poland, Portugal, Slovenia, Spain and Switzerland. A total of 14 273 cycles were reported, 29.4% of which involved IVF/ICSI with the couple's own gametes, 47.1% were oocyte donations and 22.3% were IVF or ICSI with semen donation. Additionally, 7714 IUI with sperm donation were registered. Information regarding the countries of origin was very incomplete and not reliable enough to draw any meaningful conclusions. The main reasons reported by patients were to have access to a technique not legally available in their home countries (41.7%) or to seek a higher quality treatment (16.6%).

Fertility preservation {#sec17}
----------------------

Twelve countries were able to provide data on fertility preservation: Albania, Belarus, Belgium, the Czech Republic, France, Greece, Italy, Macedonia, Poland, Portugal, Slovenia and Spain. There were 3659 cases with oocyte cryopreservation and 10 590 cases with ejaculated sperm collection and cryopreservation reported. All other forms of preservation were carried out in 614 cases (prepubertal ovarian tissue, postpubertal ovarian tissue, prepubertal testicular tissue, postpubertal testicular tissue and epididymal sperm).

Only four countries report non-medical oocyte cryopreservation, and three countries report non-medical ejaculated semen collection and cryopreservation. In all other cases, preservation is only carried out for medical reasons.

At this moment, too few data were obtained to report on the outcome.

Discussion {#sec18}
==========

This is the 19th annual report of the combined activities of the European (national) registries collecting data on ART. From 1997 to 2015, the EIM Consortium of ESHRE has reported on close to 9 million treatments (8860338) leading to the birth of more than 1.6 million infants (1665994).

The present data report summarizes the totality of the data collections provided by 38 European countries (39 in 2014). For the first time, Armenia provided data. Georgia joined the EIM Consortium, but has not yet been able to submit data, nor did Croatia and Ireland for organisational reasons. Azerbaijan, Kosovo and Luxemburg have not yet joined the EIM Consortium. Another group of small European countries have not considered joining the Consortium, such as Andorra, Liechtenstein, Monaco, San Marino and the Vatican, most likely all without ART services. Excluding these eight countries, the level of completeness at the national level amounts to 88.4% and the number of reporting clinics to 90.6%, which is similar to the participation levels achieved in 2014 (92.9%, respectively 87.5%, [@ref2]). Whereas the tendency towards large ART services with more than 1000 cycles per year seems to have stabilized in recent years, there are now more middle-sized ART institutions with treatment numbers between 200 and 1000 cycles per year ([Supplementary Table SII](#sup2){ref-type="supplementary-material"}). The level of completeness is highly variable among countries with 18 countries now able to present data with complete coverage (in 2014: 14 countries).

Despite the fluctuating participation of a few countries with high frequency activities in ART, the reported treatment numbers in ART continue to rise (+9.4%, as compared to 2014) together with more children born (+7.3%, as compared to 2014). Although access to ART services is highly variable among European countries, the proportion of children born after ART continues to rise, particularly in those countries with optimal access to ART. In 2015 up to 6.6% of all newborn babies in Denmark ([Supplementary Table SIV](#sup4){ref-type="supplementary-material"}) were born after ART (in 2014: 6.4%).

When comparing the 2015 with the 2014 data sets, all treatment modalities in ART were used more frequently except IVM and FOR ([Table I](#TB1){ref-type="table"}). Whereas the preponderance of ICSI over IVF seems to be stabilizing ([Fig. 1](#f1){ref-type="fig"}), FER is becoming more and more important over fresh treatments and the treatment numbers of FER now exceed those of IVF. Since 2014, the elective freezing of all oocytes and embryos is being recorded systematically ([Supplementary Tables SV](#sup5){ref-type="supplementary-material"} and [SVI](#sup6){ref-type="supplementary-material"}): when comparing the 2014 and the 2015 data sets, the prevalence of freezing all embryos is on the rise, less so is freezing of all oocytes. Other treatment modalities with a rapidly gaining momentum are PGT and ED.

As in previous years, fewer embryos are now being replaced per treatment cycle. More and more treatments are being performed in which only one embryo is transferred, elective or not (37.7%, [Fig. 2](#f2){ref-type="fig"}). Whereas the transfer of three or more embryos is rapidly disappearing in most countries, even the transfer of two embryos has become less prevalent in recent years ([Fig. 2](#f2){ref-type="fig"}). SET is predominantly carried out in a few countries, the same as in previous years, and those countries are the ones with fewer multiple deliveries. Unfortunately, the same goes for the few countries in which three or more embryos are being transferred. Legal and financial constraints may be the main drivers for this practice ([@ref6]), but also attitudes among physicians and patients ([@ref10]).

This impressive shift in the ET strategy has not yet translated into a major change in the number of multiple deliveries ([Table IV](#TB4){ref-type="table"}). Whereas birth rates of triplets have been on the decline ever since the early recordings by the EIM Consortium, the incidence of twin deliveries has dropped to a much lesser extent. The proportion of premature deliveries of twins and triplets remained similar to previous years. The proportion of premature deliveries (\<37 weeks) of singletons per ET has risen from 0.96% in 2006 to 1.77% in 2015 ([Fig. 3](#f3){ref-type="fig"}). Singleton pregnancies after ART are prone to a higher risk of obstetric complications, including prematurity ([@ref12]; [@ref11]; [@ref9]), but pregnancy outcome does not depend on the number of retrieved oocytes ([@ref8]).

Two cases of maternal death were reported in 2015, but the exact conditions under which these events occurred were not given ([Supplementary Table SXVI](#sup16){ref-type="supplementary-material"}). Other complications of ART, such as OHSS, infections and haemorrhage, remain prevalent at low frequencies. Foetal reduction for the prevention of multiple births is reported by 15 countries. All these numbers, however, most likely are under-reported.

Under-reporting of treatment numbers leads to overestimation of the efficacy of outcome of the offered treatments and at the same time to an underestimation of safety. The steady rise in ART activities in all European countries clearly demonstrates that ART has become an integral part of medical care and has a significant and measurable impact on society, and for that reason data on both efficacy and safety should therefore be of interest to all stakeholders, not least to the patients themselves. Data collection can only be optimized in the presence of good governance ([@ref3]). Compulsory data collection systems have been shown previously to be more effective than voluntary systems: countries with voluntary registries provided more incomplete data sets due to partial reporting ([Supplementary Table SIII](#sup3){ref-type="supplementary-material"}). In addition, modern software systems enable prospective registration of cycle by cycle data sets instead of aggregate data, which are collected retrospectively. Currently, aggregate data submission by single ART institutions to the national registries is still the most commonly used method for reporting ([Supplementary Table SIII](#sup3){ref-type="supplementary-material"}). Coherent and systematic data registration and monitoring of all treatment outcomes should become mandatory in ART and must be considered as an indicator of excellent quality of care and good governance.

The instalment of prospective data registration is more and more urgent in light of the current rapid expansion of freezing technology, allowing the long-term storage of gametes, embryos and gonadal tissues ([@ref1]). Infertility treatments are being segmented into small treatment units, for which the outcome cannot be reported within a 1-year period as was done in the past. Traditionally, the data collection organized and managed by the EIM Consortium is cross-sectional and based on annual data reporting. A concept for prospective follow-up of infertility treatment outcomes has been elaborated earlier ([@ref1]). This would require the development of a European data collection software tool including an international coding system, with which the different therapeutic steps of infertile individuals and couples can be traced prospectively, even if they change the treating institution or their country of origin.

The organisation of data collection, as managed by EIM, must be further developed towards real surveillance and vigilance in ART ([@ref7]). Surveillance is defined by the continuous and systematic collection of health data (here related to ART and its outcome) needed for the analysis and interpretation of trends in medical care with a special focus on safety. That goal can best be achieved if data submission to the national registries becomes compulsory.

Practitioners, professional bodies, and national and European political bodies have a duty to realise that such therapies require appropriate logistical and financial support to set up national reporting electronic databases, ideally a pan-European centralised data collection ([@ref1]), to monitor not only the efficiency and safety of therapy but also the long-term health of children born after treatment. The creation of a unique individual patient European coding system will ensure all aspects of an ever-increasing spectrum of ART care can be measured and analysed thus ensuring full surveillance and vigilance. The concept of evolving the current cross-sectional register towards prospective surveillance and vigilance of care in ART will take years to become a reality and will require top down support from national and supranational health care authorities. Such a concept can only be supported by all stakeholders of ART, including the patients, and should be motivated by the desire to provide care with excellence.
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Armenia {#sec25}
=======

Mr Eduard Hambartsoumian, Fertility Center, IVF Unit, 4 Tigvan Nets, 375 010 Yerevan, Armenia; Tel: +374 10 544 368; E-mail <Hambartsoumian@hotmail.com>
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Dr Elena Petrovskaya (Alena Piatrouskaya), ART centre 'Embryo', Filimonova 53, 220053 Minsk, Belarus. Tel. +375 293 830 570; E-mail: <elenaembryoby@gmail.com>

Dr Oleg Tishkevich, Centre For Assisted Reproduction 'Embryo' Belivpul, Filimonova Str. 53, 220 114 Minsk, Belarus. Tel: +375 296 222 722; Fax: +375 172 376 404; Mobile: +375 296 222 722; E-mail: <tishol@tut.by>
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Dr Kris Bogaerts, I-Biostat, Kapucijnenvoer 35 bus 7001, 3000 Leuven, Belgium. Tel: +32 (0) 16 33 68 90; Fax: +32 (0) 16 33 70 15; E-mail: <Kris.Bogaerts@med.kuleuven.be>

Prof. Christine Wyns, Gynaecology-Andrology, Cliniques Universitaires Saint Luc, Service FIV-Andrology, Université Catholique de Louvain; Av. Hippocrate, 10, 1200 Brussels, Belgium. Tel: +32 27646576; Fax: +32 27649050; Mobile: +32 477943374; E-mail: <christine.wyns@uclouvain.be>

Bosnia {#sec29}
======

Professor Dr Devleta Balic, Zavod za humanu reprodukciju 'Dr Balic', Kojsino 25, 75 000 Tuzla, Bosnia--Herzegovina. Tel: +387 35 260 650, Mobile: +387 611 402 22; E-mail <drbalic@bih.net.ba>

Professor Dr Sanja Sibincic, Health Center Medico-S, Jevrejska 58/A, 78000 Banja Luka, Bosnia--Herzegovina. Tel: +387 512 321 00; Mobile: +387 655 159 42; E-mail <sanjasibincic@gmail.com>

Bulgaria {#sec30}
========

Irena Antonova, ESHRE certified clinical embryologist (2011), Ob/Gyn Hospital Dr Shechterev, 25--31, Hristo Blagoev Strasse, 1330 Sofia, Bulgaria. Tel: +359 887 127 651; E-mail: <irendreaming@gmail.com>

Cyprus {#sec31}
======

Dr Michael Pelekanos, AKESO Fertility Centre, 1, Pavlou Nirvana strasse, 3021 Limassol, Cyprus. Tel: +357 99645333; Fax: +357 25824477; Mobile +30 6944248433; E-mail: <pelekanos@akeso.com>

Czech Republic {#sec32}
==============

Dr Karel Rezabek, Medical Faculty, University Hopsital, CAR-Assisited Reproduction Center, Gyn/Ob Departement, Apolinarska 18, 12000 Prague, Czech Republic. Tel: +420 224 967 479; Fax: +420 224 922 545; Mobile: +420 724 685 276; E-mail: <krezabek@vfn.cz>

Mgr. Jitka Markova, Institute of Health Information and Statistics of the Czech Republic, Palackeho namesti 4, 12801 Prague, Czech Republic. Tel: +420 224 972 832; Mobile: +420 721 827 532; E-mail: <jitka.markova@uzis.cz>

Denmark {#sec33}
=======

Dr Josephine Lemmen, Vitanova, Fertility clinic, Vester Voldgade 106, 1552 Copenhagen, Denmark. Tel: +45 333 371 01; E-mail: <jglemmen@gmail.com>

Estonia {#sec34}
=======

Dr Deniss Sõritsa, Tartu University Hospital and Elitre Clinic, Tartu, Estonia. Tel.: +372 740 9930; Fax: +372 740 9931; E-mail: <soritsa@hotmail.com>

Finland {#sec35}
=======

Prof. Mika Gissler, THL National Institute for Health and Welfare, P.O.Box 30, 00271 Helsinki, Finland. Tel: +385 29524 7279; E-mail: <mika.gissler@thl.fi>

Dr Sari Pelkonen, Oulu University Hospital, Department of Obstetrics and Gynaecology, P.O. Box 23, 90 029 Oys, Finland. Tel:+358 83153040; E-mail <sari.pelkonen@fimnet.fi>

France {#sec36}
======

Dr Fabienne Pessione, Agence de la biomedecine, 1 av stade de France, 93 Saint Denis, France; Tel: +33 1 5593 69 46; E-mail: <fabienne.pessione@biomedecine.fr>

Prof. Jacques de Mouzon, 15--29 rue Guilleminot, 75014 Paris, France; Mobile: +33 662 062 274; Tel: +33 143 224 679; E-mail: <jacques.de.mouzon@gmail.com>

Germany {#sec37}
=======

Dr Andreas Tandler---Schneider; Fertility Center Berlin; Spandauer damm 130; 14050 Berlin; Germany; Tel: +49 30 233 20 81 10; Fax: +49 30 233 20 81 19; E-mail: <tandler-schneider@fertilitycenter-berlin.de>

Greece {#sec38}
======

Prof. Sophia Kalantaridou; National Authority of Medically Assisted Reproduction, Ploutarxou 3, P.O. 10675 Athens; Tel: +30 213 2072000; E-mail: <secretary@eaiya.gov.gr>

Hungary {#sec39}
=======

Prof. Janos Urbancsek, Semmelweis University, 1^st^ Dept. of Ob/Gyn, Baross utca 27, 1088 Budapest, Hungary. Tel: +36 1266 01 15; Fax: +36 1266 01 15; E-mail: <urbjan@noi1.sote.hu>

Prof. G. Kosztolanyi, University of Pecs, Dept. of Medical Genetics and Child Development, Jozsef A.u;7., 7623 Pecs, Hungary. Tel: +36 72535977; Fax: +36 7 2535972; E-mail: <gyorgy.kosztolanyi@aok.pte.hu>

Iceland {#sec40}
=======

Mr Hilmar Bjorgvinsson, IVF Klinikin Reykjavik, Alfheimum 74, 104 Reykjavik, Iceland. Tel: +354 430 4000; Fax: +354 430 4040; E-mail: <Hilmar.bjorgvinsson@ivfklinikin.is>

Ireland {#sec41}
=======

Dr Edgar Mocanu, Human Assisted Reproduction Ireland Rotunda Hospital, HARI Unit, Master's House, Parnell Square, 1 Dublin, Ireland. Tel: +353 180 72 732; Mobile: + 353 86 818 839; Fax: +353 18 727 831; E-mail: <emocanu@rcsi.ie>

Jennifer Cloherty, Galway Fertility, Western distribution Road, Rahoon, Ireland. Tel: 35361476800; E-mail: <JCloherty@GFU.ie>

Italy {#sec42}
=====

Dr Giulia Scaravelli, Istituto Superiore di Sanità, Registro Nazionale della Procreazione Medicalmente Assistita, CNESPS, Viale Regina Elena, 299, 00161 Roma. Tel: +3906 499 04050; Fax: +39064 99 04 324; E-mail: <giulia.scaravelli@iss.it>

Dr Roberto de Luca, Istituto Superiore di Sanità, Registro Nazionale della Procreazione Medicalmente Assistita, CNESPS, Viale Regina Elena, 299, 00161 Roma. Tel: +3906 499 04320; E-mail: <roberto.deluca@iss.it>

Kazachtstan {#sec43}
===========

Prof. Dr Vyacheslav Lokshin, The Urban Center of Human reproduction, Tole Be Street 99, 50012 Almaty, Kazakhstan. Tel: +7 727 234 3434; Fax: +7 727 264 66 15; Mobile: +7 701 755 8209; E-mail: <vyacheslav.lokshin@ipsen.kz>

Dr Sholpan Karibayeva, The Urban Center of Human reproduction, Tole Be Street 99, 50012 Almaty, Kazakhstan. Tel: +7 727 237 2118; E-mail: <sh.karibaeva@gmail.com>

Latvia {#sec44}
======

Dr Valeria Magomedova, Jusu Arsti Private Clinic, Apuzes 14, 1046 Riga, Latvia. Tel: +371 678 700 29; Fax: +371 678 704 29; E-mail: <godunova@inbox.lv>

Lithuania {#sec45}
=========

Raminta Bausyte, Vilnius University Hospital Santaros Clinics, Santaros Fertility Center, Simono Staneviciaus 64--69, 07113 Vilnius, Lithuania. Tel: +370 620 86826, Email: <raminta.bausyte@gmail.com>

Leva Masliukaite, Academic Medical Center, Cener for Reproductive Medicine, Ijburglaan, 1086ZJ Amsterdam, The Netherlands; Tel: +31 653 688 815; E-mail: <i.masliukaite@amc.uva.nl>

Macedonia {#sec46}
=========

Mr Zoranco Petanovski, Hospital ReMedika, Nas. Zelezara, 1000 Skopje, Macedonia. Tel: +389 224 475 45; Fax: +389 226 031 00; E-mail: <zpetanovski@yahoo.com>

Malta {#sec47}
=====

Dr Jean Calleja-Agius, University of Malta, 12, Mon Nid, Gianni Faure Street, TXN2421 Tarxien, Malta. Tel: +356 216 930 41; Mobile: +356 995 536 53; E-mail: <jean.calleja-agius@um.edu.mt>

Moldova {#sec48}
=======

Prof. Dr Veaceslav Moshin, Medical Director at Repromed Moldova, Center of Mother @ Child Protection, State Medical and Pharmaceutical University 'N.Testemitanu', Bd. Cuza Voda 29/1, Chisinau, Republic of Moldova. Tel: +37322 263855; Mobile: +37369724433; E-mail: <mosin@repromed.md>; veaceslavmoshin\@yahoo.com

Montenegro {#sec49}
==========

Dr Tatjana Motrenko Simic, Human Reproduction Center Budva, Prvomajska 4, 85310 Budva, Montenegro, Tel.: +382 33402432; Mobile: +382 69 052 331; E-mail: <motrenko@t-com.me>

Dragana Vukicevic, Hospital 'Danilo I', Humana reprodukcija, Vuka Micunovica bb, 86000 Cetinje, Montenegro. Tel: +382 675 513 71; E-mail: <vukicevic.dragana@yahoo.com>

The Netherlands {#sec50}
===============

Dr Jesper M.J. Smeenk, St Elisabeth Hospital Tilburg, Dept. of obstetrics and Gynaecology, Hilv, The Netherlands. Tel: +31 13 539 31 08; Mobile: +31 622 753 853; E-mail: <j.smeenk@elisabeth.nl>,

Norway {#sec51}
======

Dr Liv Bente Romundstad, Spiren Fertility Clinic, Nardoskrenten 11, 7032 Trondheim, Norway. Tel: +47 73523000; Mobile: +47 90550207; E-mail <libero@klinikkspiren.no>

Poland {#sec52}
======

Dr Anna Janicka, VitroLive, Kasprzaka 2A, 71-074 Szczecin, Poland. Tel: +48 226 543 525; E-mail: <anna.janicka@vitrolive.pl>

Portugal {#sec53}
========

Prof. Dr Carlos Calhaz---Jorge, CNPMA, assembleia da Republica, Palacio de Sao Bento, 1249-068 Lisboa, Portugal. Tel: +351 21 391 93 03; Fax: +351 21 391 75 02; E-mail: <calhazjorgec@gmail.com>

Ms Ana Rita Laranjeira, CNPMA, Assembleia da Republica, Palaio de Sao Bento 1249-068 Lisboa, Portugal, Tel: +351 21 391 93 03; Fax: +351 21 391 75 02; E-mail: <cnpma.correio@ar.parlamento.pt>

Romania {#sec54}
=======

Mrs Ioana Rugescu, Gen Secretary of AER Embryologist association and Representative for Human Reproduction Romanian Society. Tel: +40744500267; E-mail: <irugescu@rdsmail.ro>

Dr Bogdan Doroftei, Univ. of Medicine and Pharmacy Iasi; Teaching Hospital Obgyn 'Cuza Voda'; Cuza Voda Str. 34; 700038 Iasi; Romania. Tel: +40 232 213 000/int. 176; Mobile: +40 744 515 297; E-mail <bogdandoroftei@gmail.com>; <bogdan.doroftei@umfiasi.ro>

Russia {#sec55}
======

Dr Vladislav Korsak, International Center for Reproductive Medicine, General Director, Liniya 11, Building 18B, Vasilievsky Island, 199034 St-Petersburg, Russia C.I.S. Tel: +7 812 328 2251; Fax: +7 812 327 19 50. Mobile: +7921 9651977; E-mail: <korsak@mcrm.ru>

Serbia {#sec56}
======

Prof. Nebojsa Radunovic, Institute for Obstetrics and Gynecology,Visegradska 26, 11000 Belgrade, Serbia. Tel: +38 111 361 55 92; Fax: +38 111 361 56 03; Mobile: +381 63 200 204; E-mail: <radunn01@gmail.com>

Dr Sci. Nada Tabs, Klinika za ginekologiju i akuserstvo, Klinicki centar Vojvodine, Branimira Cosica 37, 21000 Novi Sad, Serbia. Mobile: +381 63 50 81 85; E-mail: <nada.tabs@yahoo.com>

Slovenia {#sec57}
========

Dr Irma Virant-Klun, University Medical Centre Ljubljana, Departement of Obstetrics and Gynecology, Slajmerjeva 3, 1000 Ljubljana, Slovenia. Tel: +386 1522 60 13; Fax: +386 1431 43 55; Mobile:+38631625774 E-mail: <irma.virant@kclj.si>

Spain {#sec58}
=====

Mrs Irene Cuevas Saiz, Hospital General de Alicante, Infertility Dept., Av Pintor Baeza, 12, 03010 Valencia, Spain; Tel: +34 961972000; Fax: +34 91 799 4407; Mobile: 0034677245650; E-mail: <cuevas_ire@gva.es>

Dr Fernando Prados Mondéjar, Hospital de Madrid-Montepríncipe, HM Fertility Center Monteprincipe, C/Montepríncipe 25, 28660 Boadilla del Monte, Spain; Tel: +34 917 089 931; Mobile: +34 646 737 237; E-mail: <fernandojprados@gmail.com>

Sweden {#sec59}
======

Prof. Christina Bergh, Sahlgrenska University Hospital, Department of Obstetrics and Gynaecology, Bla Straket 6, 413 45 Göteborg, Sweden. Tel: +4631 3421000, +46736 889325; Fax: +4631 418717; Mobile: +46 736 889325; E-mail <Christina.bergh@vgregion.se>

Switzerland {#sec60}
===========

Dr Elisabeth Berger-Menz, Kinderwunschpraxis Berger, FMH Gyn/GH, Brembartenstrasse 119, 3012 Berne, Switzerland. Tel: +41 31 305 84 17; E-mail: <praxis@berger-gyn.ch>

Ms Maya Weder, Administration FIVNAT, Postfach 754, 3076 Worb, Switzerland. Tel: +41 (0)31819 76 02; Fax: +41 (0)31819 89 20; E-mail: <fivnat@bluewin.ch>

UK {#sec61}
==

Mr Howard Ryan, Data Analyst H.F.E.A, 10 Spring Gardens, London SW1A 2BU, UK. Tel: +44 (0)207291 8203; E-mail: <Howard.Ryan@HFEA.GOV.UK>

Mr Richard Baranowski, Deputy Information Manager, Human Fertilization and Embryology Authority (HFEA), Finsbury Tower, 103--105 Bunhill Row, London EC1 Y 8HF, UK. Tel: +44 (0) 20 7539 3329; Fax: +44 (0) 20 7377 1871; E-mail: <Richard.baranowski@hfea.gov.uk>

Ukraine {#sec62}
=======

Professor Dr Mykola Gryshchenko, IVF Clinic Implant Ltd, Academician V.I.Gryshchenko Clinic for Reproductive Medicine, 25 Karl Marx Str., 61 000 Kharkiv, Ukraine. Tel: +380 57 124522; Fax: +380 57 705070703; Mobile +380 57 705070703; E-mail: <nggryshchenko@gmail.com>

[^1]: ESHRE pages content is not externally peer reviewed. The manuscript has been approved by the Executive Committee of ESHRE.
